Fluorometholone ophthalmic Alternatives Compared
| Fluorometholone ophthalmic | Opcon-A | Naphcon-A |
|
|---|
| Fluorometholone ophthalmic | Opcon-A (naphazoline / pheniramine) | Naphcon-A (naphazoline / pheniramine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Steroid Responsive Inflammatory Conditions, Eyelash Hypotrichosis, Eye Redness/Itching, Eye Redness. fluorometholone ophthalmic may also be used for purposes not listed in this medication guide. View more |
Over-the-counter
Prescribed for Eye Redness/Itching. Opcon-A may also be used for purposes not listed in this medication guide. |
Over-the-counter
Prescribed for Eye Redness/Itching. Naphcon-A may also be used for purposes not listed in this medication guide. |
Related suggestions Eye Redness/Itching
|
|||||||||||||||
| More about Fluorometholone ophthalmic | More about Opcon-A (naphazoline / pheniramine) | More about Naphcon-A (naphazoline / pheniramine) | ||||||||||||||||
| Generic Status | ||||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
|||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Fluorometholone ophthalmic has an average rating of 7.0 out of 10 from a total of 8 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 14% reported a negative effect. |
Opcon-A has an average rating of 5.6 out of 10 from a total of 35 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 37% reported a negative effect. |
Naphcon-A has an average rating of 7.3 out of 10 from a total of 3 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
See also: fluorometholone ophthalmic side effects in more detail. |
See also: Opcon-A side effects in more detail. |
See also: Naphcon-A side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all fluorometholone ophthalmic prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Naphcon-A prices |
||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Eflone, Flarex, FML, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. | Other naphazoline / pheniramine brands include: AK-Con-A, Eye Allergy Relief, Naphcon-A, Visine-A | Other naphazoline / pheniramine brands include: AK-Con-A, Eye Allergy Relief, Opcon-A, Visine-A | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
|
Category C
Risk cannot be ruled out
|
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 39 drugs are known to interact with fluorometholone ophthalmic:
|
A total of 48 drugs are known to interact with Opcon-A:
|
A total of 48 drugs are known to interact with Naphcon-A:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
September 04, 1985 |
N/A |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.